Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEV.L Regulatory News (DEV)

  • There is currently no data for DEV

GM Statement

20 Jan 2020 12:00

RNS Number : 3391A
Dev Clever Holdings PLC
20 January 2020
 

THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014

NOT FOR PUBLICATION OR RELEASE IN OR INTO THE UNITED STATES OR AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA, OR ANY PROVINCE OR TERRITORY THEREOF OR TO OR FOR THE ACCOUNT OF ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES OR ANY PERSON RESIDENT IN AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA.

20 January 2020

 

Dev Clever Holdings plc

("Company")

Result of General Meeting, Completion of the Placing and Convertible Loan Notes

Dev Clever Holdings plc (DEV) a leading developer of consumer engagement solutions and career development platforms, is pleased to announce that all resolutions put to shareholders at the Company's General Meeting held earlier today have been passed. As a result, the 43,785,107 new ordinary shares of 1p each in the Company being issued pursuant to the placing of shares announced on 20 December 2019 ("Placing") are expected to be admitted to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange tomorrow, 21 January 2020 ("Admission"), to complete the Placing. 

On Admission, the Company will have 432,186,843 ordinary shares of 1p each in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of ordinary shares and voting rights is 432,186,843.

The above figure of 432,186,843 may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In addition, the Company announces that its controlling shareholder, Christopher Jeffries, has agreed to sell 50,000,000 ordinary shares of 1p each that he holds in the capital of the Company to third party purchasers procured by its broker, Novum Securities Limited, at 1p per share ("Sale"). On completion of the Sale, Christopher Jeffries will hold 200,000,000 ordinary shares of the Company, representing 46.28 per cent of the Company's issued share capital.

Christopher Jeffries and the Company have entered into a convertible loan note, pursuant to which the net proceeds of the Sale, amounting to £400,000 (after tax, costs and commission), will be provided to the Company as subscription amount for convertible loan notes ("Notes"). The Notes will be convertible into ordinary shares of 1p each in the capital of the Company at Christopher Jeffries' option, at any time, subject to, among other things, the Company not being required to publish a prospectus in connection with the issue of shares on conversion of the Notes and no obligations under Rule 9 of the City Code on Takeovers and Mergers being triggered by such issue of shares. Unless previously repaid or converted, the Notes will be redeemed at par by the Company on the fifth anniversary of the convertible loan note. The Notes will bear a zero coupon.

The subscription amount is intended to be used by the Company to provide additional working capital to support the marketing and roll out of its Launchpad careers platform and accompanying VICTAR virtual reality careers experience across the UK and for the adaptation of the platform for the North American market. It is expected that both Launchpad and VICTAR will be launched in the North American market, starting in the USA, from April 2020.

 

ENQUIRIES:

Dev Clever Holdings plc 

 

Christopher JeffriesChief Executive Officer and Executive ChairmanNicholas YdlibiFinance Director 

+44 (0) 845 459 0774 

+44 (0) 330 058 2922 

 

 

Novum Securities Limited - Joint BrokerColin Rowbury 

 

 

+44 (0) 20 7399 9400

 

Pello Capital - Joint Broker

Daniel Gee

 

 

 

+44 (0) 203 700 2534

 

 

- ANNOUNCEMENT ENDS -

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
GMSUROARRNUAUAR
Date   Source Headline
21st Dec 20207:00 amRNSAgreement
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:36 pmRNSPrice Monitoring Extension
7th Dec 202011:00 amRNSPrice Monitoring Extension
1st Dec 20207:00 amRNSUpdate on Subscription Agreement
13th Nov 20202:30 pmRNSHolding(s) in Company
6th Nov 20207:00 amRNSHeads of Terms
2nd Nov 20207:00 amRNSUpdate To Subscription Agreement
27th Oct 20202:15 pmRNSHolding(s) in Company
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSTR1
5th Oct 20207:00 amRNSTotal Voting Rights
23rd Sep 20207:00 amRNSNew Appointment
17th Sep 20207:00 amRNSPartnership announcement
16th Sep 202010:10 amRNSHolding(s) in Company
15th Sep 20202:15 pmRNSHolding in Company
14th Sep 20207:00 amRNSExercise of warrants
11th Sep 202010:00 amRNSHolding(s) in Company
10th Sep 20207:00 amRNSTrading update and new contract
8th Sep 20204:37 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSIssue of Equity
3rd Sep 20207:00 amRNSIssue of Equity
1st Sep 20207:00 amRNSUpdate to Right to Subscribe
18th Aug 20203:45 pmRNSHolding(s) in Company
3rd Aug 20207:01 amRNSDirector/PDMR Shareholding
3rd Aug 20207:00 amRNSIssue of Equity
29th Jul 20207:00 amRNSIssue of equity and conversion of debt
27th Jul 20207:05 amRNSHalf-year Report
27th Jul 20207:00 amRNSUpdate to Right to Subscribe
17th Jul 202010:00 amRNSHolding(s) in Company
16th Jul 20209:31 amRNSHolding(s) in Company
15th Jul 20207:00 amRNSHolding(s) in Company
10th Jul 20203:00 pmRNSHolding(s) in Company
9th Jul 20207:00 amRNSProduct Launch
6th Jul 20207:00 amRNSCommercial agreement
8th Jun 20202:05 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSVirtual Open Week
26th May 20207:00 amRNSDirectorate Change
22nd May 20207:00 amRNSExercise of employee share options
21st May 202010:30 amRNSDirector/PDMR Shareholding
14th May 20203:50 pmRNSDirector/PDMR Shareholding
13th May 202010:30 amRNSRight to Subscribe
13th May 202010:30 amRNSDirector/PDMR Shareholding
6th May 20207:00 amRNSProduct Launch
4th May 20209:00 amRNSPrice Monitoring Extension
30th Apr 20201:30 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSContract
20th Apr 20204:41 pmRNSSecond Price Monitoring Extn
20th Apr 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.